Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 3.40
STAA's Cash to Debt is ranked higher than
56% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.56 vs. STAA: 3.40 )
Ranked among companies with meaningful Cash to Debt only.
STAA' s Cash to Debt Range Over the Past 10 Years
Min: 0.08  Med: 1.83 Max: 9.66
Current: 3.4
0.08
9.66
Equity to Asset 0.64
STAA's Equity to Asset is ranked higher than
53% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. STAA: 0.64 )
Ranked among companies with meaningful Equity to Asset only.
STAA' s Equity to Asset Range Over the Past 10 Years
Min: 0.29  Med: 0.66 Max: 0.81
Current: 0.64
0.29
0.81
F-Score: 2
Z-Score: 4.96
M-Score: -2.66
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -12.38
STAA's Operating margin (%) is ranked lower than
72% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.71 vs. STAA: -12.38 )
Ranked among companies with meaningful Operating margin (%) only.
STAA' s Operating margin (%) Range Over the Past 10 Years
Min: -27.22  Med: -10.13 Max: 4.43
Current: -12.38
-27.22
4.43
Net-margin (%) -11.30
STAA's Net-margin (%) is ranked lower than
69% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. STAA: -11.30 )
Ranked among companies with meaningful Net-margin (%) only.
STAA' s Net-margin (%) Range Over the Past 10 Years
Min: -30.97  Med: -11.67 Max: 2.15
Current: -11.3
-30.97
2.15
ROE (%) -21.27
STAA's ROE (%) is ranked lower than
75% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. STAA: -21.27 )
Ranked among companies with meaningful ROE (%) only.
STAA' s ROE (%) Range Over the Past 10 Years
Min: -88.78  Med: -25.34 Max: 5.2
Current: -21.27
-88.78
5.2
ROA (%) -13.68
STAA's ROA (%) is ranked lower than
73% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. STAA: -13.68 )
Ranked among companies with meaningful ROA (%) only.
STAA' s ROA (%) Range Over the Past 10 Years
Min: -43.45  Med: -12.52 Max: 3.01
Current: -13.68
-43.45
3.01
ROC (Joel Greenblatt) (%) -31.15
STAA's ROC (Joel Greenblatt) (%) is ranked lower than
71% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.36 vs. STAA: -31.15 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
STAA' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -131.74  Med: -29.40 Max: 22.07
Current: -31.15
-131.74
22.07
Revenue Growth (3Y)(%) 5.00
STAA's Revenue Growth (3Y)(%) is ranked higher than
51% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. STAA: 5.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
STAA' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -12.5  Med: -6.95 Max: 9.5
Current: 5
-12.5
9.5
» STAA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

STAA Guru Trades in Q3 2014

Chuck Royce 233,276 sh (unchged)
Steven Cohen 31,500 sh (-71.23%)
» More
Q4 2014

STAA Guru Trades in Q4 2014

Chuck Royce Sold Out
Steven Cohen Sold Out
» More
Q1 2015

STAA Guru Trades in Q1 2015

Jim Simons 17,600 sh (New)
» More
Q2 2015

STAA Guru Trades in Q2 2015

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with STAA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 44.25
STAA's Forward P/E is ranked lower than
93% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.84 vs. STAA: 44.25 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 6.32
STAA's P/B is ranked lower than
95% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.31 vs. STAA: 6.32 )
Ranked among companies with meaningful P/B only.
STAA' s P/B Range Over the Past 10 Years
Min: 1.38  Med: 6.43 Max: 17.54
Current: 6.32
1.38
17.54
P/S 3.36
STAA's P/S is ranked lower than
75% of the 255 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. STAA: 3.36 )
Ranked among companies with meaningful P/S only.
STAA' s P/S Range Over the Past 10 Years
Min: 0.34  Med: 3.38 Max: 9.91
Current: 3.36
0.34
9.91
Current Ratio 2.85
STAA's Current Ratio is ranked higher than
54% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. STAA: 2.85 )
Ranked among companies with meaningful Current Ratio only.
STAA' s Current Ratio Range Over the Past 10 Years
Min: 1.06  Med: 2.55 Max: 3.77
Current: 2.85
1.06
3.77
Quick Ratio 1.98
STAA's Quick Ratio is ranked higher than
57% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. STAA: 1.98 )
Ranked among companies with meaningful Quick Ratio only.
STAA' s Quick Ratio Range Over the Past 10 Years
Min: 0.55  Med: 1.46 Max: 2.37
Current: 1.98
0.55
2.37
Days Inventory 217.19
STAA's Days Inventory is ranked lower than
79% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.52 vs. STAA: 217.19 )
Ranked among companies with meaningful Days Inventory only.
STAA' s Days Inventory Range Over the Past 10 Years
Min: 154.29  Med: 197.23 Max: 291.16
Current: 217.19
154.29
291.16
Days Sales Outstanding 64.02
STAA's Days Sales Outstanding is ranked higher than
51% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 64.05 vs. STAA: 64.02 )
Ranked among companies with meaningful Days Sales Outstanding only.
STAA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.28  Med: 50.88 Max: 66.26
Current: 64.02
36.28
66.26
Days Payable 83.28
STAA's Days Payable is ranked higher than
67% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.85 vs. STAA: 83.28 )
Ranked among companies with meaningful Days Payable only.
STAA' s Days Payable Range Over the Past 10 Years
Min: 53.24  Med: 72.89 Max: 137.15
Current: 83.28
53.24
137.15

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 9.78
STAA's Price/Net Current Asset Value is ranked lower than
60% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. STAA: 9.78 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
STAA' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 2.23  Med: 12.22 Max: 45.33
Current: 9.78
2.23
45.33
Price/Tangible Book 6.73
STAA's Price/Tangible Book is ranked lower than
69% of the 239 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.36 vs. STAA: 6.73 )
Ranked among companies with meaningful Price/Tangible Book only.
STAA' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.94  Med: 7.09 Max: 23.8
Current: 6.73
0.94
23.8
Price/Projected FCF 20.19
STAA's Price/Projected FCF is ranked lower than
97% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. STAA: 20.19 )
Ranked among companies with meaningful Price/Projected FCF only.
STAA' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.87  Med: 8.94 Max: 128.14
Current: 20.19
0.87
128.14
Price/Median PS Value 0.99
STAA's Price/Median PS Value is ranked higher than
59% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.13 vs. STAA: 0.99 )
Ranked among companies with meaningful Price/Median PS Value only.
STAA' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.13  Med: 0.95 Max: 2.88
Current: 0.99
0.13
2.88
Earnings Yield (Greenblatt) (%) -3.97
STAA's Earnings Yield (Greenblatt) (%) is ranked lower than
70% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. STAA: -3.97 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
STAA' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -4.01  Med: 0.50 Max: 0.9
Current: -3.97
-4.01
0.9

More Statistics

Revenue(Mil) $73
EPS $ -0.21
Beta0.96
Short Percentage of Float11.00%
52-Week Range $6.04 - 10.76
Shares Outstanding(Mil)39.89

Analyst Estimate

Dec15 Dec16 Dec17 Dec18
Revenue(Mil) 76 81 87 94
EPS($) -0.07 -0.05 0.14 0.22
EPS without NRI($) -0.07 -0.05 0.14 0.22

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:SR3.Germany,
Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company develops, produces, and markets intraocular lenses. The Company was incorporated in the state of California in 1982. It was reincorporated in Delaware in 1986. The Company along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The lenses are used in corrective or refractive surgery. The Company also makes lenses for use in surgery that treats cataracts. The Company operates as one operating segment, the ophthalmic surgical market. The Company maintains manufacturing and administrative facilities in the United States, Switzerland and Japan. The Company competes with other elective surgical procedures such as laser vision correction or LASIK, for those consumers who are looking for an alternative to eyeglasses or contact lenses to correct their vision.
» More Articles for STAA

Headlines

Articles On GuruFocus.com
Weekly CFO Sells Highlight: MHR, DISCA, BCR, STAA, PEGA, IDXX Aug 22 2011 

More From Other Websites
How STAAR Surgical (STAA) Stock Stands Out in a Strong Industry Feb 10 2016
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Feb 09 2016
STAAR Surgical Company and Memira Holding Announce Cooperation Agreement for Memira's Eye Clinics... Feb 09 2016
STAAR Surgical to Report Fourth Quarter Results on March 2, 2016 Feb 03 2016
STAAR Surgical (STAA) Enters Oversold Territory Feb 01 2016
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 11 2016
STAAR SURGICAL CO Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Dec 17 2015
Stephen C. Farrell Appointed to STAAR Surgical Board of Directors Dec 17 2015
Stephen C. Farrell Appointed to STAAR Surgical Board of Directors Dec 17 2015
STAAR SURGICAL CO Financials Dec 08 2015
Update in Lawsuit for Investors in STAAR Surgical Company (NASDAQ:STAA) Shares Announced by... Dec 08 2015
STAAR Surgical Company Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty Dec 01 2015
Do Hedge Funds Love STAAR Surgical Company (NASDAQ:STAA)? Nov 25 2015
STAAR SURGICAL CO Files SEC form 10-Q, Quarterly Report Nov 04 2015
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Oct 30 2015
Staar Surgical reports 3Q loss Oct 28 2015
Staar Surgical reports 3Q loss Oct 28 2015
STAAR Surgical Co Earnings Call scheduled for 4:30 pm ET today Oct 28 2015
STAAR Surgical Reports Third Quarter 2015 Results Oct 28 2015
STAAR SURGICAL CO Files SEC form 8-K, Results of Operations and Financial Condition Oct 28 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK